Immunotherapy has been established as an important area in the therapy of malignant
diseases. Immunogenicity sufficient for immune recognition and subsequent elimination can …

Synthetic reactive oxygen species (ROS)-responsive biomaterials have emerged as a useful
platform for regulating critical aspects of ROS-induced pathologies and can improve such …

The traditional drug delivery techniques are unresponsive to the altering metabolic states of
the body and fail to achieve target specific drug delivery, which results in toxic plasma …

Hepatogenous diabetes is a complex disease that is typified by the simultaneous presence
of type 2 diabetes and many forms of liver disease. The chief pathogenic determinant in this …

Targeting of CD44 isoforms containing exon v6 (CD44v6) represents a viable strategy for
the therapy and/or early diagnosis of metastatic cancers of the epithelium (eg gastric and …

Glioblastoma (GBM) is the most frequent and aggressive primary tumor of the brain and
averages a life expectancy in diagnosed patients of only 15 months. Hence, more effective …

Introduction In recent years, to improve the precision of drug delivery and reduce toxicity
associated from the uncontrolled drug release at off-target locations, extensive efforts have …

The tumor microenvironment (TME) plays a pivotal role in cancer development and
progression. In this line, revealing the precise mechanisms of the TME and associated …

Several evolution strategies for in vivo computation are proposed with the aim of realizing
tumor sensitization and targeting (TST) by externally manipulable nanoswimmers. In such …

Acute brain injuries such as traumatic brain injury and stroke affect 85 million people a year
worldwide, and many survivors suffer from long-term physical, cognitive, or psychosocial …